Christopher D Byrne

Has grant

University of Southampton

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Early identification of patients with pancreatic cancer: a pilot study to evaluate the utility of Faecal elastase-1 and 13C mixed triglyceride breath test as screening tools in high-risk individuals.

Open Date: 2020-04-01

Close Date: 2021-04-01

Grant: Close

Investigation of inflammation and dysbiosis in non alcoholic fatty liver disease

Open Date: 2019-04-01

Close Date: 2020-03-01

Grant: Close

Role of adipose tissue function in fatty liver disease

Open Date: 2018-10-01

Close Date: 2021-09-01

Grant: Close

Dietary and nutritional assessment in pancreatic cancer patients undergoing surgical intervention

Open Date: 2018-10-01

Close Date: 2020-10-01

Grant: Close

Is Fat in the Liver a marker of post-Pregnancy Glycaemic Deterioration in women with Gestational Diabetes (FLiP GD2)?

Open Date: 2018-09-01

Close Date: 2020-09-01

Articles (30)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (18)

Sam Wilding

University of Southampton

UNITED KINGDOM

View details

Alessandro Mantovani

ITALY

View details

Giovanni Targher

ITALY

View details

THERESA HYDES

University of Southampton

UNITED KINGDOM

View details

Ryan Buchanan

University of Southampton

UNITED KINGDOM

View details

Seungho Ryu

SOUTH KOREA

View details

Hazel Inskip

University of Southampton

UNITED KINGDOM

View details

Yoosoo Chang

Sungkyunkwan University School of Medicine

SOUTH KOREA

View details

Norbert Stefan

GERMANY

View details

Adam Frampton

Assoc. Professor in Surgical Oncology & Head of Oncology

University of Surrey

UNITED KINGDOM

View details

Minneke J. Coenraad

NETHERLANDS

View details

Won Sohn

Sungkyunkwan University School of Medicine

SOUTH KOREA

View details

Justin Davies

Professor of Paediatric Endocrinology

University of Southampton

UNITED KINGDOM

View details

Zaed Z Hamady

University Hospital Southampton NHS Foundation Trust

UNITED KINGDOM

View details

Young Min Cho

SOUTH KOREA

View details

Deborah JG Mackay

University of Southampton

UNITED KINGDOM

View details

Hwa Yeon Ko

Sungkyunkwan University

SOUTH KOREA

View details

Josh Bilson

University of Southampton

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Christopher D Byrne

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (30)

Non-invasive tests of fibrosis in the management of MASLD: revolutionising diagnosis, progression and regression monitoring

Glucagon‐Like Peptide‐1 Receptor Agonists Improve MASH and Liver Fibrosis: A Meta‐Analysis of Randomised Controlled Trials

Author Correction: Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment

A call for doubling the diagnostic rate of at-risk metabolic dysfunction-associated steatohepatitis

Metabolic dysfunction-associated steatotic liver disease a multisystem disease: Assessing the cost effectiveness of pharmacotherapies

Author Correction: Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment

Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment

Impact of Metabolic Syndrome Traits on Kidney Disease Risk in Individuals with MASLD: A UK Biobank Study

Metabolite Changes Associated with Resectable Pancreatic Ductal Adenocarcinoma

Utility and cost-effectiveness of LiverMultiScan for MASLD diagnosis: a real-world multi-national randomised clinical trial

Body Composition and Metabolism in Adults With Molecularly Confirmed Silver-Russell Syndrome

Associations between cuprotosis‐related genes and the spectrum of metabolic dysfunction‐associated fatty liver disease: An exploratory study

Risk of hepatic events associated with use of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists, and thiazolidinediones among patients with metabolic dysfunction-associated steatotic liver disease

Causal relationship between key genes and metabolic dysfunction‐associated fatty liver disease risk mediated by immune cells: A Mendelian randomization and mediation analysis

Serum bile acid profiles are associated with heart failure with preserved ejection fraction in patients with metabolic dysfunction‐associated fatty liver disease: An exploratory study

Unraveling the epidemiology of metabolic dysfunction-associated liver cancer: Insights from mixed etiologies, regional variations, and gender disparities

Bile Acids as Emerging Players at the Intersection of Steatotic Liver Disease and Cardiovascular Diseases

Recompensation in MASLD-related cirrhosis via metabolic bariatric surgery

Baseline and change in serum uric acid level over time and resolution of nonalcoholic fatty liver disease in young adults: The Kangbuk Samsung Health Study

High‐Sensitivity C‐Reactive Protein Is Associated With Heart Failure Hospitalization in Patients With Metabolic Dysfunction‐Associated Fatty Liver Disease and Normal Left Ventricular Ejection Fraction Undergoing Coronary Angiography

Nonalcoholic fatty liver disease and risk of incident young-onset hypertension: Effect modification by sex

Coronary artery calcium and risk of chronic kidney disease in young and middle-aged adults

Liver fibrosis markers and all cause mortality in people with type 2 diabetes: A population based study (The Ayrshire Diabetes Outcomes Cohort (ADOC) Study)

Elevated Glycated Haemoglobin (HbA1c) Is Associated with an Increased Risk of Pancreatic Ductal Adenocarcinoma: A UK Biobank Cohort Study

Comparative effects of non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease on risk of incident cardiovascular events: a meta-analysis of about 13 million individuals

Time to consider a holistic approach to the treatment of non-alcoholic fatty liver disease in obese young people?

Comparison of cardiovascular mortality between MAFLD and NAFLD: A cohort study

Comparative Associations of Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction–Associated Fatty Liver Disease With Coronary Artery Calcification: A Cross-Sectional and Longitudinal Cohort Study

Non-alcoholic fatty liver disease and risk of new-onset heart failure: an updated meta-analysis of about 11 million individuals

Alcohol consumption and metabolic syndrome: Clinical and epidemiological impact on liver disease

Collaborators (18)

Sam Wilding

Alessandro Mantovani

Giovanni Targher

THERESA HYDES

Ryan Buchanan

Seungho Ryu

Hazel Inskip

Yoosoo Chang

Norbert Stefan

Adam Frampton

Minneke J. Coenraad

Won Sohn

Justin Davies

Zaed Z Hamady

Young Min Cho

Deborah JG Mackay

Hwa Yeon Ko

Josh Bilson

Make your next move.